Mercaptopurine Anhydrous

CHEMBL1425 Phase 4 已批准 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

152.2 g/mol

LogP

—

Phase

4

An anhydrous form of mercaptopurine, a chemotherapy drug used to treat leukemia and other blood cancers by disrupting cancer cell DNA synthesis.

分子量

152.1800 g/mol

LogP

0.00

TPSA

85.20 Å²

Lipinski 五规则

符合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure

Embed this structure

SMILES

Sc1ncnc2nc[nH]c12

InChI

InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)

Molecular Formula

C5H4N4S

HBD / HBA

2 / 2

可旋转键数

0

重原子数

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

An anhydrous form of mercaptopurine, a chemotherapy drug used to treat leukemia and other blood cancers by disrupting cancer cell DNA synthesis.

Yes, Mercaptopurine Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1425. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 667490. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

正在寻找患者友好型信息？

Mercaptopurine Anhydrous 在 PillFYI 上

结构

快速数据

分子式: C5H4N4S

外部链接

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.